Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
AstraZeneca
Healthtrust
Moodys
Boehringer Ingelheim
Accenture
Covington
Colorcon
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eli Lilly And Co
BASAGLAR
insulin glargine
SOLUTION;SUBCUTANEOUS205692NDAEli Lilly and Company0002-7715-595 SYRINGE in 1 CARTON (0002-7715-59) > 3 mL in 1 SYRINGE (0002-7715-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
Fuji
Novartis
Cipla
Chinese Patent Office
Colorcon
Merck
Farmers Insurance
Baxter

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot